Use code BLUE125 to save big on select memberships!

Researchers Find Link Between Genetic Mutations and Cancer Treatment Resistance

July 26, 2022

 • 

Read time:

<5 mins
Multiple Myeloma Purple Green Scientific
Presented by Health Lab

A team of researchers from the University of Michigan Rogel Cancer Center has discovered a prevalence of activated key oncogenic pathways in patients with an aggressive form of multiple myeloma, much more than previously thought. Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology, explains how he and his team found a link between mutations and RASopathies, a particular group of genetic syndromes in patients with relapsed treatment-resistant multiple myeloma, a first of its kind discovery.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.